Combining DMT with SSRIs Bolsters DMT’s Efficacy in Treating Severe Depression
ResearchThe psychedelic renaissance movement was ignited by the idea that classical psychedelics like psilocybin, MDMA, LSD and DMT are potentially more effective in treating mental health conditions than traditional medications such as SSRIs. Now,…
Monks on Mushrooms: ‘Descending the Mountain’ Pairs Zen with Psychedelics
Culture, Research"Descending the Mountain" is one of the best documentaries about psychedelics since "Fantastic Fungi."
Psychedelics Can Relieve Chronic Pain, New Survey Suggests
ResearchA survey of 170 volunteers found chronic pain was relieved by both macro- and microdoses of classic psychedelics, including LSD and psilocybin.
MDMA Successfully Treats PTSD in Another Phase 3 Trial Sponsored by MAPS
Research, Treatment"MDMA-assisted therapy for PTSD is on track to be considered for approval by the FDA in 2024," says MAPS founder and president Rick Doblin.
The Millennium’s Primer Series: Neuroinflammation as a Barrier to the Success of Psychedelic-Assisted Therapies
Research, TreatmentInitial clinical trials into this exciting frontier have unveiled promising outcomes, showcasing remarkable improvements in clinical results using anti-inflammatory, nanoliposomal products prior to the application of a psychedelic agent.
Michigan Lawmakers Urge Congress to Consider Psychedelics to Treat Veterans
Policy, ResearchState senators are calling on U.S. Congress officials overseeing veteran care to "prioritize research and investment" into psychedelics and other mental health treatment techniques that could reduce suicides.
5 Fascinating Insights From a Top Psychedelics Researcher
Education, ResearchDr. Matthew Johnson, one of the most published psychedelics researchers in the world, shares two decades worth of wisdom.
New Study Determines Psilocybin Provides ‘Rapid and Sustained Antidepressant Effect’
Research, TreatmentOne of the largest studies yet lends more evidence to the view that psilocybin "may hold promise as a novel intervention for major depressive disorder."
Psilocybin v. Escitalopram: Study Compares Effects on Depression
ResearchResearchers probe treating one of the greatest psychological issues of our time with two different drugs.
Over One-Third of Under 50s Are Open to Psychedelic Trials for Mental Health Treatment
ResearchAside from psilocybin, those aged between 18-24 were most interested psychedelic trials with ketamine (27%) and MDMA (26%).